title: Drug selection and dosing in pregnant cancer patients: insights from clinical pharmacokinetics.
authors.affiliation: CALG Cancer in Pregnancy French Group, Paris; Department of Gynaecology and Obstetrics, Teaching Hospital Trousseau.
authors.forename: P
authors.initials: P
authors.lastname: Berveiller
authors.affiliation: CALG Cancer in Pregnancy French Group, Paris; Department of Gynaecology and Obstetrics, Teaching Hospital Tenon, Assistance Publique-Hôpitaux de Paris, Pierre et Marie Curie Paris VI University, Paris.
authors.forename: L
authors.initials: L
authors.lastname: Selleret
authors.affiliation: CALG Cancer in Pregnancy French Group, Paris; Department of Cancer Medicine, Gustave Roussy Cancer Institute, University of Paris Sud, Paris, France. Electronic address: olivier.mir@gustaveroussy.fr.
authors.forename: O
authors.initials: O
authors.lastname: Mir
mesh_terms: D000077143:Docetaxel; D004317:Doxorubicin / Q000493:pharmacokinetics*; D015251:Epirubicin / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000493:pharmacokinetics*; D011247:Pregnancy; D043823:Taxoids / Q000493:pharmacokinetics*
chemical_list: D043823:Taxoids; D000077143:Docetaxel; D015251:Epirubicin; D004317:Doxorubicin; D017239:Paclitaxel